As such, we can design efficacious functional vaccines that mimic the 3D epitopes. Our first-generation HER-2 peptide vaccines (316–339 and 628–647) were identified prior to the publications ...
New HCV vaccine approaches, including peptide, recombinant protein, DNA and vector-based vaccines, have recently reached Phase I/II human clinical trials. Some of these technologies have generated ...
IO Biotech announced promising findings regarding a novel peptide vaccine designed to counter the immunosuppressive effects of Transforming Growth Factor Beta (TGF-β) in solid tumors. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback